Navigation Links
Max Neeman International ISO 27001:2005 Certified for Information Security Management Systems
Date:1/5/2011

RESEARCH TRIANGLE PARK, N.C., Jan. 5, 2011 /PRNewswire/ -- Max Neeman announces the grant of ISO 27001:2005 certificate; one of only a few Indian CROs to be certified for Information Security.  

(Logo: http://photos.prnewswire.com/prnh/20110105/CL25129LOGO)

This updated certification of the world renowned British Standard for Information Security Management Systems (BS 7799-2:2002) is the standard outlining requirements for an Information Security Management System (ISMS). An ISMS helps in designing; implementing and maintaining a set of processes and systems to manage the risk posed to the information assets of an organization. Thus, helps in achieving the standards of – confidentiality, integrity and availability necessary for information security.

India is the hub of outsourced clinical research and this growth can be impeded by the threat posed to the security of the data generated in the trials. Sponsor companies have been seen to be apprehensive about information security.  

Max Neeman is involved in the development of various novel research molecules and handles crucial information related to the development of these molecules. ISO 27001 certification assures that the systems, processes and controls are rigorous to protect the integrity and confidentiality of information.  The certification helps Max Neeman in assuring the clients on integrity and confidentiality of the data generated in clinical research.  

The ISO 27001:2005 certification Max Neeman has achieved, assures that systems, processes and controls are stringent and sound enough to protect the integrity and confidentiality of information. Max Neeman is in par with all the other global Contract Research Organizations and in meeting global standards.

About Max Neeman International

Max Neeman International is a leading India-based CRO. Our specialty is that we offer services for the successful conduct of Pha
'/>"/>

SOURCE Max Neeman International
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Max Neeman International Initiates Large Phase IV Trial on Type II Diabetes with 25,000 Subjects Across 1,200 Sites
2. Max Neeman International Expands Upon Cardiology and Device Trial Experience to Meet Increased Medical Device Development in India
3. Max Neeman International Expands Data Management Services with Conversion Into CDISC Standard Data Model
4. Max Neeman International and AMEDON Collaborate to Increase EDC Performance
5. Max Neeman International Expands Specialized Surgical Team for Clinical Trials
6. Transposagen and Cellular Dynamics International Cross-License Technologies for Induced Pluripotent Stem Cells
7. Dongsheng Pharmaceutical International Co. Granted Exclusive Sales Rights for Thymosin Alpha 1 Injection
8. Mettler-Toledo International Inc. Announces Webcast of Presentation at J.P. Morgan Healthcare Conference
9. PAREXEL International to Present at J.P. Morgan Healthcare Conference
10. Bacterin International Holdings to Present at the OneMedForum San Francisco 2011
11. SRI International Completes Integration of Sarnoff Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... Aug. 20, 2014 Reportlinker.com announces ... available in its catalogue: Wireless ... RFID, Zigbee, UWB WWAN, WMAN, WLAN and ... Kalorama Information,s Wireless Opportunities ... Zigbee, UWB WWAN, WMAN, WLAN and other ...
(Date:8/20/2014)... 20, 2014 Reportlinker.com announces that a ... catalogue: Global Coatings for Medical Devices ... This report analyzes the worldwide markets ... by the following Product Segments: Active Coatings, Protective ... provides separate comprehensive analytics for the US, ...
(Date:8/20/2014)... LYNDHURST, N.J. , Aug. 20, 2014  Amerigen ... Amerigen Pharmaceuticals Co. Ltd., has received Chinese FDA ... Mecobalamin 0.5 mg Tablets into the ... of a marketing and distribution agreement with Sinochem ... product at its US FDA approved and China ...
Breaking Medicine Technology:Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 2Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 3Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 4Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 5Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 6Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 7Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 8Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 9Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 10Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 11Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 12Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 13Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 14Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 15Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 16Global Coatings for Medical Devices Industry 2Global Coatings for Medical Devices Industry 3Global Coatings for Medical Devices Industry 4Global Coatings for Medical Devices Industry 5Global Coatings for Medical Devices Industry 6Global Coatings for Medical Devices Industry 7Global Coatings for Medical Devices Industry 8Global Coatings for Medical Devices Industry 9Global Coatings for Medical Devices Industry 10Global Coatings for Medical Devices Industry 11Global Coatings for Medical Devices Industry 12Global Coatings for Medical Devices Industry 13Global Coatings for Medical Devices Industry 14Global Coatings for Medical Devices Industry 15Global Coatings for Medical Devices Industry 16Global Coatings for Medical Devices Industry 17Global Coatings for Medical Devices Industry 18Global Coatings for Medical Devices Industry 19Global Coatings for Medical Devices Industry 20Global Coatings for Medical Devices Industry 21
... primary endpoint not met; plausibly,confounded by survival ... YORK, April 16, 2007 /PRNewswire-FirstCall/ -- ImClone,Systems ... results from the EPIC study - a ... ERBITUX(R),(Cetuximab) plus irinotecan to irinotecan alone in ...
... ProNAi Therapeutics,Inc., a biopharmaceutical company pioneering a ... interference (DNAi), today,announced that its lead oncology ... vivo efficacy in,xenograft mice for a number ... difficult-to-treat Burkitt's Lymphoma., Dr. Richard D. Gill, ...
Cached Medicine Technology:Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 2Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 3Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 4Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 5Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 6Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 7Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 8Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 9ProNAi Announces Preclinical Success for PNT2258 Therapeutic -,Curative Events in Xenograft Mice for Difficult-to-Treat,Non-Hodgkin's Lymphoma 2
(Date:8/20/2014)... of the most persistent and deadliest infectious diseases in ... year. , Scientists who study tuberculosis have long debated ... from humans in Africa to seals and sea lions ... it to Native people there before Europeans landed on ... Seals as a Source of New World Human Tuberculosis," ...
(Date:8/20/2014)... found a novel approach to treating cancer - using ... of Science Translational Medicine shows that cancer ... by nerves that are linked to cancer stem cells. ... Botox made the treatment cheap, safe and efficient. The ... and will soon start testing on humans. , The ...
(Date:8/20/2014)... Madison, WI (PRWEB) August 20, 2014 ... in the Inc. 500|5000 list of the fastest ... third consecutive year. Ranking at No. 2,941, Quincy Bioscience ... successful businesses in the United States. , Quincy Bioscience ... patented ingredient apoaequorin – a protein originally discovered in ...
(Date:8/20/2014)... Caddis Partners LLC, has built one ... real estate company in recent years, developing or acquiring ... $500 million, including more than $100 million last year ... expansions into new geographic regions and a wider array ... pleased to announce an enhanced brand identity that includes ...
(Date:8/20/2014)... Hallandale Beach, Florida (PRWEB) August 20, 2014 ... in Florida, with the help of their experienced surgeons ... thousands of patients to regain their lost or inaccurate ... technology for performing Lasik surgery is making it possible ... an aging disease which occurs normally in people in ...
Breaking Medicine News(10 mins):Health News:New research shows seals and sea lions likely spread tuberculosis to humans 2Health News:New research shows seals and sea lions likely spread tuberculosis to humans 3Health News:Treating gastric cancer -- with Botox 2Health News:Quincy Bioscience Recognized in Inc. 500|5000 List of America’s Fastest Growing Companies for Third Consecutive Year 2Health News:Caddis Rebrands to Emphasize Its Growth, Expanded Capabilities 2Health News:Caddis Rebrands to Emphasize Its Growth, Expanded Capabilities 3Health News:Caddis Rebrands to Emphasize Its Growth, Expanded Capabilities 4Health News:Braverman Eye Center Now Offers Multifocal PresbyLasik in Florida by Trained Surgeons 2
... Women who have experienced hot flushes and other symptoms ... developing the most common forms of breast cancer than postmenopausal ... recent study by researchers at Fred Hutchinson Cancer Research Center. ... relationship between menopausal symptoms and breast cancer risk are available ...
... TUESDAY, Jan. 25 (HealthDay News) -- It,s hard to help ... long-term is even tougher. But obese children whose parents took ... weight and kept it off for the next two years, ... study shows that targeting parents -- rather than the children ...
... Reinberg HealthDay Reporter , TUESDAY, Jan. 25 (HealthDay ... the U.S. Food and Drug Administration is asking a panel ... to stricter standards. Over the past five years, there ... used to shock a patient in cardiac arrest in hopes ...
... COLUMBUS, Ohio For troubled war veterans, a friendly bartender ... a sympathetic ear. A pilot study suggests that some ... in need of mental health services and help connect them ... surveyed 71 bartenders employed at Veterans of Foreign Wars posts ...
... of safe and reliable human embryonic stem (hES) cells ... has faced challenges in developing cultures that can consistently ... Standard culture systems use mouse "feeder" cells and media ... but such animal productbased media can contaminate the cells. ...
... 25, 2011) A new study led by researchers ... Children,s Hospital and Colorado Health Outcomes Program (COHO) at ... barriers, facilitators and alternative approaches to providers sending ... Reminder or recall messages, usually in the form of ...
Cached Medicine News:Health News:Hot flushes are linked with a significant reduction in breast cancer risk 2Health News:Changing Parental Behavior May Help Obese Kids Lose Weight 2Health News:Changing Parental Behavior May Help Obese Kids Lose Weight 3Health News:FDA Looking at Tougher Standards for External Defibrillators 2Health News:Bartenders may have role in assisting troubled war veterans 2Health News:Bartenders may have role in assisting troubled war veterans 3Health News:UCLA researchers eliminate major roadblock in regenerative medicine 2Health News:UCLA researchers eliminate major roadblock in regenerative medicine 3Health News:New study finds reminders for immunizations challenging for pediatric practices 2Health News:New study finds reminders for immunizations challenging for pediatric practices 3
Ahmed Glaucoma Valve (small size)....
... established. Provides a robust and durable drainage ... on the globe. Pressure Ridge Molteno Implants ... by Tenons tissue, acts as a Pressure ... range of implants allows the surgeon to ...
... a robust and durable drainage system. Preplaced ... globe. Pressure Ridge Molteno Implants have a ... tissue, acts as a Pressure sensitive biological ... implants allows the surgeon to choose the ...
... Baerveldt Glaucoma Implants feature a low ... and reduced complications. The single-quadrant insertion is ... area seton plate to be installed with ... patented fenestrations of the Baerveldt implant were ...
Medicine Products: